Submitted by Anonymous (not verified) on 17 January 2025 - 15:30
Human medicines European public assessment report (EPAR): Padcev, enfortumab vedotin, Date of authorisation: 13/04/2022, Revision: 5, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Padcev, enfortumab vedotin, Date of authorisation: 13/04/2022, Revision: 5, Status: Authorised